NCT02128022View on ClinicalTrials.gov

Cardioprotective Effects of GLP-1 and Their Mechanisms

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Angina Pectoris
Interventions
DRUG

GLP-1 (7-36) amide

Infusion of GLP-1 (7-36) amide 1.2 pmol/Kg/min

DRUG

Glibenclamide

Oral Glibenclamide 5mg

Trial Locations (1)

CB23 3RE

Papworth Hospital, Cambridge

All Listed Sponsors
lead

Papworth Hospital NHS Foundation Trust

OTHER_GOV

NCT02128022 - Cardioprotective Effects of GLP-1 and Their Mechanisms | Biotech Hunter | Biotech Hunter